Home › NDC Lookup › RxCUI directory › RxCUI 348719

Tobramycin 60 MG/ML Inhalation Solution — RxCUI 348719

Name: Tobramycin 60 MG/ML Inhalation Solution (RxCUI 348719)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 348719 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI348719

Official nameTobramycin 60 MG/ML Inhalation Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known astobramycin 300 MG per 5 ML Inhalation Solution; tobramycin 300 MG in 5 ML Inhalation Solution

FDA products mapped15

Package NDCs mapped17

Reported Medicaid activity (SDUD)10,235 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tobramycin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Tobramycin is only effective when it gets directly into your bloodstream, and it's very poorly absorbed if swallowed. That's why it's always given as an injection or IV infusion —...
Why am I getting tobramycin by injection instead of taking a pill?
That's a really important question, and the honest answer is: it can, which is why your kidney function and tobramycin levels in your blood will be checked regularly during treatme...
Will this antibiotic hurt my kidneys or my hearing?

📖 Read our full Tobramycin Injection guide →

🕸️ Concept Web — How Tobramycin 60 MG/ML Inhalation Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Tobramycin 60 MG/ML Inhalation Solution RxCUI 348719 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Tobramycin 10627 IN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Kitabis 1596026 BN
- Tobi 220329 BN
Dose forms 8

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Tobramycin Inhalation Solution 2108548 SCDF
- Tobramycin Inhalant Product 1157108 SCDG
- Tobramycin Inhalation Solution [Kitabis] 2108550 SBDF
- Tobramycin Inhalation Solution [Tobi] 2108552 SBDF
- Kitabis Inhalant Product 1596029 SBDG
- Tobi Inhalant Product 1179098 SBDG
- Inhalation Solution 346161 DF
- Inhalant Product 1151123 DFG
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Tobramycin 60 MG/ML 316830 SCDC
- Tobramycin 60 MG/ML Inhalation Solution [Kitabis] 1596030 SBD
- Tobramycin 60 MG/ML Inhalation Solution [Tobi] 213194 SBD
- Tobramycin 60 MG/ML [Kitabis] 1596027 SBDC
- Tobramycin 60 MG/ML [Tobi] 573117 SBDC

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Tobramycin 60 MG/ML SCDC · 316830
Tobramycin Inhalation Solution SCDF · 2108548
Tobramycin Inhalant Product SCDG · 1157108

Brand-Name Concepts

Tobramycin 60 MG/ML Inhalation Solution [Kitabis] SBD · 1596030
Tobramycin 60 MG/ML Inhalation Solution [Tobi] SBD · 213194
Tobramycin 60 MG/ML [Kitabis] SBDC · 1596027
Tobramycin 60 MG/ML [Tobi] SBDC · 573117
Tobramycin Inhalation Solution [Kitabis] SBDF · 2108550
Tobramycin Inhalation Solution [Tobi] SBDF · 2108552
Kitabis Inhalant Product SBDG · 1596029
Tobi Inhalant Product SBDG · 1179098
Kitabis BN · 1596026
Tobi BN · 220329

📦 FDA Products & Package NDCs

15 products · 17 package NDCs

17 package NDCs map to RxCUI 348719 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00093-4085-63	56 AMPULE in 1 CARTON (0093-4085-63) / 5 mL in 1 AMPULE	Tobramycin	Teva Pharmaceuticals USA, Inc.	2013-11-19
24492-0850-56	14 POUCH in 1 CARTON (24492-850-56) / 4 AMPULE in 1 POUCH /...	Kitabis Pak	Pari Respiratory Equipment, Inc.	2015-02-19
42571-0408-92	14 POUCH in 1 CARTON (42571-408-92) / 4 AMPULE in 1 POUCH (...	Tobramycin	Micro Labs Limited	2024-01-01
43598-0605-56	14 POUCH in 1 CARTON (43598-605-56) / 4 AMPULE in 1 POUCH (...	Tobramycin Inhalation Solution	Dr. Reddy's Laboratories Inc.	2019-05-14
43598-0605-58	56 POUCH in 1 CARTON (43598-605-58) / 1 AMPULE in 1 POUCH (...	Tobramycin Inhalation Solution	Dr. Reddy's Laboratories Inc.	2020-10-29
47335-0171-49	14 POUCH in 1 CARTON (47335-171-49) / 4 AMPULE in 1 POUCH (...	Tobramycin	Sun Pharmaceutical Industries, Inc.	2020-02-28
49502-0345-73	56 POUCH in 1 CARTON (49502-345-73) / 4 AMPULE in 1 POUCH (...	TOBI	Viatris Specialty LLC	2022-06-23
49502-0345-74	56 POUCH in 1 CARTON (49502-345-74) / 14 AMPULE in 1 POUCH...	TOBI	Viatris Specialty LLC	2026-06-25
59651-0129-56	14 POUCH in 1 CARTON (59651-129-56) / 4 AMPULE in 1 POUCH (...	TOBRAMYCIN	Aurobindo Pharma Limited	2021-01-22
60687-0731-83	30 POUCH in 1 CARTON (60687-731-83) / 1 AMPULE in 1 POUCH (...	Tobramycin	American Health Packaging	2024-05-19
65162-0914-46	56 AMPULE in 1 CARTON (65162-914-46) / 5 mL in 1 AMPULE	Tobramycin	Amneal Pharmaceuticals LLC	2014-07-13
67877-0678-70	56 POUCH in 1 CARTON (67877-678-70) / 7 AMPULE in 1 POUCH (...	Tobramycin	Ascend Laboratories, LLC	2021-04-02
68180-0962-56	56 POUCH in 1 CARTON (68180-962-56) / 4 AMPULE in 1 POUCH /...	Tobramycin	Lupin Pharmaceuticals, Inc.	2018-06-12
70644-0899-99	14 POUCH in 1 CARTON (70644-899-99) / 4 AMPULE in 1 POUCH /...	Tobramycin Inhalation Solution Pak	Genericus, Inc.	2016-07-11
70756-0604-56	14 POUCH in 1 CARTON (70756-604-56) / 4 AMPULE in 1 POUCH (...	TOBRAMYCIN	Lifestar Pharma LLC	2023-06-30
72603-0430-56	14 POUCH in 1 CARTON (72603-430-56) / 4 AMPULE in 1 POUCH (...	TOBRAMYCIN	NorthStar RxLLC	2024-08-01
76204-0029-56	14 POUCH in 1 CARTON (76204-029-56) / 4 AMPULE in 1 POUCH /...	Tobramycin	Ritedose Pharmaceuticals, LLC	2025-03-25

Observed labelers: Dr. Reddy's Laboratories Inc. (2) · Viatris Specialty LLC (2) · American Health Packaging (1) · Amneal Pharmaceuticals LLC (1) · Ascend Laboratories, LLC (1) · Aurobindo Pharma Limited (1) · +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J7682	Tobramycin non-comp unit	14	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.